Skip to main content

GlaxoSmithKline is first drug company to use Apple’s ResearchKit

What makes Apple’s ResearchKit more attractive than your typical research institution-funded study is the standardization of data collection, as well as the ability to have participants enroll on their own and participate in studies from the comfort of their homes, drastically minimizing costs across the board. Interestingly enough, however, GlaxoSmithKline is the first pharmaceutical company to conduct a study through ResearchKit, reports Bloomberg.

Over a three-month period, Glaxo aims to involve 300 participants in a rheumatoid arthritis study that aims to include participants’ physical and emotional symptoms, such as pain levels and mood. More standardized data, such as the utilization of the iPhone’s sensors in order to record motion through a guided wrist exercise, will also be included.

The hope for the arthritis study, according to Glaxo head of clinical innovation and digital platforms group Rob DiCicco, is to inform any future clinical trials the drugmaker might want to conduct. However, there are potential shortcomings with using ResearchKit to conduct studies, something DiCicco partially acknowledged when he said, “One thing we’ll learn is whether we made it compelling enough to make you want to interact with it every day.”

Indeed, there remains the possibility that participants will grow weary of constantly entering information into the app, as well as the possibility that the data itself will be skewed. More specifically, since the cheapest iPhone retails for $400, the participant pool might be skewed toward those with more money in their pockets.

Even so, much hinges on the success of Glaxo’s study. Not only is the company breaking new ground by becoming the first drug company to utilize ResearchKit, but the success of its study might allow for other pharmaceutical firms to conduct ResearchKit studies of their own. Furthermore, Glaxo’s entry diversifies the kind of institutions that have utilized ResearchKit up until now, which have included hospitals and universities.

Apple also has a stake in Glaxo’s app, given how the Cupertino, California-based company is seemingly committed to its health initiative. During its March “Loop You In” event, Apple announced CareKit, an open-source platform that compliments ResearchKit by giving patients the power to manage their medical conditions and care.

Editors' Recommendations

Williams Pelegrin
Former Digital Trends Contributor
Williams is an avid New York Yankees fan, speaks Spanish, resides in Colorado, and has an affinity for Frosted Flakes. Send…
Apple takes the title as first $1 trillion U.S. company
apple file system

Apple is officially the first publicly traded United States company to be valued at $1 trillion. The news comes only a couple days after revealing its strong third-quarter earnings.

The company specifically reached $1 trillion early on Thursday, August 2, when its stock rose almost 3 percent -- reaching a high of $207.05 per share.

Read more
Smart doorbells and Apple HomeKit are not compatible, at least for now
Ring Wi-Fi Enabled Video Doorbell smart home devices

Doorbells are not coming to Apple HomeKit anytime soon. At least, that seems to be what its Home Accessories listing suggests, now that Apple has purged all mentions of HomeKit-enabled doorbells. As 9to5mac reported, the page once listed the August Doorbell Cam, among others, as "coming soon." Now, it seems that they are not coming at all.

For many smart doorbell makers, the idea of HomeKit support has been a far-fetched dream for months, if not years. August initially said that it would have HomeKit support in 2016, while Ring has claimed that its video doorbell has been in testing mode with HomeKit for several months. Strangely enough, smart doorbells seem to be particularly difficult for Apple to conquer. While HomeKit has expanded its smart home integrations in the last few months, with smart locks, smart thermostats, and other such appliances, doorbells remain nowhere to be found.

Read more
New Wemo Bridge smart home hub is compatible with Apple HomeKit
wemo bridge for homekit press vignette

If you're looking to bring your smart home onto the Apple HomeKit network, Belkin and its Internet of Things brand Wemo can now help. At CES, the smart home brand announced a new version of the Wemo Bridge smart home hub, this time enabled with Apple HomeKit. While it may be annoying to have to buy an entirely different device just to ensure Apple compatibility, this is an inconvenience that Apple requires, as most HomeKit devices must have a proprietary chip inside them.

"We have made it a top priority working with Apple to ensure an incredible experience for both Wemo and HomeKit users."

Read more